Run‐Ling Wang

2.3k citations

79 papers · 1.3k · h-index 21

Impact in

Toxicology top 2%
- Bioactive Compounds and Antitumor Agents
Endocrinology, Diabetes and Metabolism top 10%
- Natural Antidiabetic Agents Studies

Papers in

Molecular Biology 59
- Protein Tyrosine Phosphatases 38
- ATP Synthase and ATPases Research 10
- Peroxisome Proliferator-Activated Receptors 7
- Receptor Mechanisms and Signaling 6
Immunology 23
- Galectins and Cancer Biology 22

Co-authors: Ying Ma (38 shared papers)Weiren Xu (21 shared papers)Shuqing Wang (13 shared papers)Kuo‐Chen Chou (2 shared papers)Xian‐Chao Cheng (17 shared papers)Peng Yu (6 shared papers)Hua Sun (6 shared papers)Weiya Li (20 shared papers)
Journals: Journal of Biomolecular Structure and Dynamics (14 papers)Oncotarget (5 papers)Bioorganic & Medicinal Chemistry Letters (5 papers)European Journal of Medicinal Chemistry (3 papers)Bioorganic Chemistry (3 papers)
Partner nations: China New Zealand United States

In The Last Decade

Run‐Ling Wang

78 papers receiving 1.3k citations

Peers

Countries citing papers authored by Run‐Ling Wang

Since Specialization

Citations

This map shows the geographic impact of Run‐Ling Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Run‐Ling Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Run‐Ling Wang more than expected).

Fields of papers citing papers by Run‐Ling Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Run‐Ling Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Run‐Ling Wang. The network helps show where Run‐Ling Wang may publish in the future.

Co-authors

The 25 scholars most cited alongside Run‐Ling Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Run‐Ling Wang Line = papers co-authored together Run‐Ling Wang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Natural Prenylchalconaringenins and Prenylnaringenins as Antidiabetic Agents: α-Glucosidase and α-Amylase Inhibition and in Vivo Antihyperglycemic and Antihyperlipidemic Effects Journal of Agricultural and Food Chemistry ·Hua Sun, Dong Wang, Xiaotong Song, Yazhou Zhang, Weina Ding, Xiaolin Peng, Xiaoting Zhang, Yashan Li, Ying Ma, Run‐Ling Wang, Peng Yu	2017	108
2	Novel Inhibitor Design for Hemagglutinin against H1N1 Influenza Virus by Core Hopping Method PLoS ONE ·Xiaobo Li, Shuqing Wang, Weiren Xu, Run‐Ling Wang, Kuo‐Chen Chou	2011	99
3	Design Novel Dual Agonists for Treating Type-2 Diabetes by Targeting Peroxisome Proliferator-Activated Receptors with Core Hopping Approach PLoS ONE ·Ying Ma, Shuqing Wang, Weiren Xu, Run‐Ling Wang, Kuo‐Chen Chou	2012	99
4	Synthesis, α-glucosidase inhibitory and molecular docking studies of prenylated and geranylated flavones, isoflavones and chalcones Bioorganic & Medicinal Chemistry Letters ·Hua Sun, Yashan Li, Xiaoting Zhang, Yanan Lei, Weina Ding, Xue Zhao, Haomeng Wang, Xiaotong Song, Qingwei Yao, Yongmin Zhang, Ying Ma, Run‐Ling Wang, Tao Zhu, Peng Yu	2015	55
5	Synthesis of 6-hydroxyaurone analogues and evaluation of their α-glucosidase inhibitory and glucose consumption-promoting activity: Development of highly active 5,6-disubstituted derivatives Bioorganic & Medicinal Chemistry Letters ·Hua Sun, Weina Ding, Xiaotong Song, Dong Wang, Mingzhu Chen, Kaili Wang, Yazhou Zhang, Peng Yuan, Ying Ma, Run‐Ling Wang, Robert H. Dodd, Yongmin Zhang, Kui Lu, Peng Yu	2017	48
6	Discovery of novel small molecule inhibitors of lysine methyltransferase G9a and their mechanism in leukemia cell lines European Journal of Medicinal Chemistry ·Shukkoor Muhammed Kondengaden, Liufei Luo, Kenneth Huang, Mengyuan Zhu, Lanlan Zang, Eudoxie Bataba, Run‐Ling Wang, Cheng Luo, Binghe Wang, Keqin Kathy Li, Peng George Wang	2016	40
7	Inhibitory activity evaluation and mechanistic studies of tetracyclic oxindole derivatives as α-glucosidase inhibitors European Journal of Medicinal Chemistry ·Hua Sun, Yazhou Zhang, Weina Ding, Xue Zhao, Xiaotong Song, Dong Wang, Yashan Li, Kailin Han, Yang Yang, Ying Ma, Run‐Ling Wang, Peng Yu	2016	37
8	The Discovery of a Novel and Selective Inhibitor of PTP1B Over TCPTP: 3D QSAR Pharmacophore Modeling, Virtual Screening, Synthesis, and Biological Evaluation Chemical Biology & Drug Design ·Ying Ma, Yuanyuan Jin, Ye‐Liu Wang, Run‐Ling Wang, Xinhua Lu, Dexin Kong, Weiren Xu	2014	31
9	Synthesis, biological evaluation and 3D-QSAR studies of 1,2,4-triazole-5-substituted carboxylic acid bioisosteres as uric acid transporter 1 (URAT1) inhibitors for the treatment of hyperuricemia associated with gout Bioorganic & Medicinal Chemistry Letters ·Jingwei Wu, Ling Yin, Yuqiang Liu, Huan Zhang, Yafei Xie, Run‐Ling Wang, Guilong Zhao	2018	30
10	Three new powerful oseltamivir derivatives for inhibiting the neuraminidase of influenza virus Biochemical and Biophysical Research Communications ·Shuqing Wang, Xian‐Chao Cheng, Wei‐Li Dong, Run‐Ling Wang, Kuo‐Chen Chou	2010	30
11	Multitargeted bioactive ligands for PPARs discovered in the last decade Chemical Biology & Drug Design ·Jun Zhang, Xin Liu, Xie Xian-bin, Xian‐Chao Cheng, Run‐Ling Wang	2016	27
12	Synthesis, biological evaluation and 3D-QSAR studies of imidazolidine-2,4-dione derivatives as novel protein tyrosine phosphatase 1B inhibitors European Journal of Medicinal Chemistry ·Meiyan Wang, Yuanyuan Jin, Hui‐Yu Wei, Lisong Zhang, Su‐Xia Sun, Xiu‐Bo Chen, Wei‐Li Dong, Weiren Xu, Xian‐Chao Cheng, Run‐Ling Wang	2015	26
13	Docking and Molecular Dynamics Simulations of Peroxisome Proliferator Activated Receptors Interacting with Pan Agonist Sodelglitazar Protein and Peptide Letters ·Xuyuan Liu, Run‐Ling Wang, Weiren Xu, Tang Li-da, Shuqing Wang, Kuo‐Chen Chou	2011	24
14	Scaffold-based novel SHP2 allosteric inhibitors design using Receptor-Ligand pharmacophore model, virtual screening and molecular dynamics Computational Biology and Chemistry ·Wen-Yan Jin, Ying Ma, Weiya Li, Honglian Li, Run‐Ling Wang	2018	22
15	SAHA-based novel HDAC inhibitor design by core hopping method Journal of Molecular Graphics and Modelling ·Lanlan Zang, Xuejiao Wang, Xiaobo Li, Shuqing Wang, Weiren Xu, Xie Xian-bin, Xian‐Chao Cheng, Huan Ma, Run‐Ling Wang	2014	21
16	3D QSAR Pharmacophore Based Virtual Screening for Identification of Potential Inhibitors for CDC25B Computational Biology and Chemistry ·Ying Ma, Honglian Li, Xiu‐Bo Chen, Wen-Yan Jin, Hui Zhou, Run‐Ling Wang	2018	21
17	The design of novel inhibitors for treating cancer by targeting CDC25B through disruption of CDC25B-CDK2/Cyclin A interaction using computational approaches Oncotarget ·Honglian Li, Ying Ma, Yu Li, Xiu‐Bo Chen, Wei‐Li Dong, Run‐Ling Wang	2017	21
18	Exploring the cause of the inhibitor 4AX attaching to binding site disrupting protein tyrosine phosphatase 4A1 trimerization by molecular dynamic simulation Journal of Biomolecular Structure and Dynamics ·Weiya Li, (unknown), Yangchun Ma, Xinhua Lu, Ying Ma, Run‐Ling Wang	2019	21
19	Design, synthesis and docking study of novel tetracyclic oxindole derivatives as α-glucosidase inhibitors Bioorganic & Medicinal Chemistry Letters ·Kailin Han, Yashan Li, Yazhou Zhang, Yuou Teng, Ying Ma, Meiyan Wang, Run‐Ling Wang, Weiren Xu, Qingwei Yao, Yongmin Zhang, Haijuan Qin, Hua Sun, Peng Yu	2015	20
20	Channel Pruning for Visual Tracking Lecture notes in computer science ·Manqiang Che, Run‐Ling Wang, Yan Lu, Yan Li, Hui Zhi, Changzhen Xiong	2019	20

About Run‐Ling Wang

Run‐Ling Wang is a scholar working on Molecular Biology, Immunology, Organic Chemistry, Toxicology and Oncology, having authored 79 papers that have together received 1.3k indexed citations. Recurring topics across this work include Protein Tyrosine Phosphatases (38 papers), Galectins and Cancer Biology (22 papers), Bioactive Compounds and Antitumor Agents (15 papers), ATP Synthase and ATPases Research (10 papers), Synthesis and biological activity (9 papers), Peroxisome Proliferator-Activated Receptors (7 papers), Receptor Mechanisms and Signaling (6 papers) and Computational Drug Discovery Methods (6 papers). The work is most often cited by research in Toxicology (91 citations), Endocrinology, Diabetes and Metabolism (174 citations), Molecular Biology (762 citations), Organic Chemistry (305 citations) and Biochemistry (61 citations). Run‐Ling Wang has collaborated with scholars based in China, New Zealand and United States. Frequent co-authors include Ying Ma, Weiren Xu, Shuqing Wang, Kuo‐Chen Chou, Xian‐Chao Cheng, Peng Yu, Hua Sun, Weiya Li, Wei‐Li Dong and Xiaobo Li. Their work appears in journals such as Journal of Biomolecular Structure and Dynamics, Oncotarget, Bioorganic & Medicinal Chemistry Letters, European Journal of Medicinal Chemistry and Bioorganic Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Run‐Ling Wang

Impact in

Papers in i

In The Last Decade

Run‐Ling Wang

Peers

Countries citing papers authored by Run‐Ling Wang

Fields of papers citing papers by Run‐Ling Wang

All Works

About Run‐Ling Wang

Explore authors with similar magnitude of impact

Papers in